Clinical Features and Management of Invasive Fungal Sinusitis with Orbital Apex : A 10-Year Retrospective Cohort Study
This 10-year retrospective cohort study of 28 patients reveals that invasive fungal sinusitis is a predominant cause of orbital apex syndrome in immunocompromised individuals, particularly those with diabetes, and despite aggressive multidisciplinary management, visual recovery remains poor compared to the higher rates of ocular motility improvement.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Deep within the skull, where the sinuses meet the eye socket, lies a narrow, crowded passageway known as the orbital apex. It is a critical bottleneck where the optic nerve, which carries visual signals to the brain, and several other nerves that control eye movement, squeeze together. When this tight space becomes inflamed or filled with pressure, a condition called orbital apex syndrome occurs. The result is often devastating: a person may lose their sight, their eyelid may droop, and their eyes may become paralyzed, unable to move in any direction. While this syndrome can be triggered by tumors, trauma, or bacteria, a particularly aggressive and deadly cause is an infection by fungi—molds that normally live harmlessly in the environment but can turn lethal when they invade the sinuses of people with weakened immune systems. For decades, doctors have struggled to treat these fungal invasions once they reach the eye socket, often finding that even with the best modern care, the damage to vision is permanent.
A team of researchers at the First Affiliated Hospital of Fujian Medical University set out to understand exactly how this plays out in real patients. They looked back over a ten-year period, from 2016 to 2026, reviewing the medical records of 28 individuals who had been diagnosed with this specific type of orbital apex syndrome. Their goal was to map out who gets sick, what causes the infection, how it is treated, and, most importantly, who actually recovers their sight. The study focused heavily on the role of invasive fungal sinusitis, a condition where fungi like Aspergillus or Mucor eat their way through tissue, spreading from the sinuses into the delicate structures of the eye. The researchers found that this condition is most common in older men, with an average age of nearly 58, and that the vast majority of these patients had a history of diabetes, a disease that weakens the body's ability to fight off such infections.
When the researchers examined the causes of the syndrome in their group, they discovered that infection was the primary driver, accounting for more than half of the cases. Among those infections, fungi were the most frequent culprit. In nearly all the suspected fungal cases, a biopsy of the tissue confirmed that the fungus had indeed invaded the area. The most common fungus found was Aspergillus, but the team also identified other types, including Rhizopus and Malassezia, using advanced genetic sequencing tools that can detect tiny traces of an organism's DNA even when traditional cultures fail to grow them. While bacteria and tumors also caused the syndrome in some patients, the fungal cases stood out as the most aggressive and difficult to manage. The patients often arrived with severe symptoms: their eyes were swollen and painful, they could not move their eyes, and most had already lost their vision, with many seeing nothing at all.
The treatment approach was a race against time, combining surgery to clear out the infected tissue and powerful medications to fight the infection. Most patients underwent endoscopic sinus surgery, a procedure where doctors use a thin, lighted tube to remove the diseased tissue from the sinuses and relieve pressure on the eye socket. They also received strong antifungal drugs, similar to how antibiotics are used for bacterial infections, but specifically designed to kill fungi. Despite these aggressive efforts, the outcome for vision was grim. Only about one-third of the patients managed to regain any useful vision after treatment. This was a stark contrast to the recovery of eye movement; while sight remained lost for most, the ability to move the eyes improved in nearly three-quarters of the patients. This difference suggests that the nerves controlling eye movement are more resilient and can recover once the pressure is relieved, whereas the optic nerve, which carries the image of the world, suffers damage that is often irreversible once the infection takes hold.
The study also highlighted how quickly the situation can deteriorate and how vital early detection is. The researchers noted that patients who received surgery within three days of their symptoms starting had a better chance of saving their vision than those who waited longer, though even early intervention could not guarantee a cure. In some cases, the infection was so severe that it mimicked the appearance of a cancer on scans, leading to initial confusion about the diagnosis. It was only through a combination of careful imaging, tissue analysis, and advanced genetic testing that the true fungal nature of the disease was confirmed. The team concluded that for doctors, the key lesson is to maintain a high level of suspicion for fungal infections in patients with diabetes who present with sudden eye problems. They emphasized that waiting for test results before starting treatment is a dangerous delay, and that a coordinated effort between surgeons, eye specialists, and infectious disease experts is essential. While the ability to move the eyes can often be restored, the window to save sight is narrow and closes rapidly, making early recognition the single most important factor in the battle against this silent, invasive threat.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.